000 | 01033 a2200301 4500 | ||
---|---|---|---|
005 | 20250517065601.0 | ||
264 | 0 | _c20160323 | |
008 | 201603s 0 0 eng d | ||
022 | _a1365-2036 | ||
024 | 7 |
_a10.1111/apt.13451 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBossa, F | |
245 | 0 | 0 |
_aLetter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma. _h[electronic resource] |
260 |
_bAlimentary pharmacology & therapeutics _cJan 2016 |
||
300 |
_a174-5 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
650 | 0 | 4 |
_aColitis _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanoma _xdrug therapy |
700 | 1 | _aPerri, F | |
700 | 1 | _aNiro, G | |
700 | 1 | _aParente, P | |
700 | 1 | _aGraziano, P | |
700 | 1 | _aAndriulli, A | |
773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 43 _gno. 1 _gp. 174-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.13451 _zAvailable from publisher's website |
999 |
_c25516053 _d25516053 |